Does DURVALUMAB Cause Pulmonary toxicity? 123 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 123 reports of Pulmonary toxicity have been filed in association with DURVALUMAB (IMFINZI). This represents 0.7% of all adverse event reports for DURVALUMAB.
123
Reports of Pulmonary toxicity with DURVALUMAB
0.7%
of all DURVALUMAB reports
17
Deaths
38
Hospitalizations
How Dangerous Is Pulmonary toxicity From DURVALUMAB?
Of the 123 reports, 17 (13.8%) resulted in death, 38 (30.9%) required hospitalization, and 5 (4.1%) were considered life-threatening.
Is Pulmonary toxicity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DURVALUMAB. However, 123 reports have been filed with the FAERS database.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Pulmonary toxicity?
AMIODARONE (886)
METHOTREXATE (811)
HYDROXYCHLOROQUINE (411)
RITUXIMAB (404)
TOCILIZUMAB (395)
LEFLUNOMIDE (364)
ABATACEPT (359)
ADALIMUMAB (326)
PEMBROLIZUMAB (318)
ETANERCEPT (291)
Which DURVALUMAB Alternatives Have Lower Pulmonary toxicity Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE